Adjuvant therapy-related shortening of survival (ATRESS): An underrated phenomenon - Authors reply Journal Article


Authors: Xu, B.; Seidman, A.; Chan, S.
Article Title: Adjuvant therapy-related shortening of survival (ATRESS): An underrated phenomenon - Authors reply
Keywords: treatment outcome; fluorouracil; cancer adjuvant therapy; disease free survival; methotrexate; letter; neoplasm; tumor volume; cyclophosphamide; drug resistance; recurrence free survival; adjuvant; phase 3 clinical trial (topic); cancer prognosis; human; priority journal
Journal Title: The Oncologist
Volume: 20
Issue: 1
ISSN: 1083-7159
Publisher: Oxford University Press  
Date Published: 2015-01-01
Start Page: 88
Language: English
DOI: 10.1634/theoncologist.2014-0284
PROVIDER: scopus
PUBMED: 25589501
PMCID: PMC4294611
DOI/URL:
Notes: Export Date: 2 February 2015 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Andrew D Seidman
    318 Seidman